Results at 3 years after transplantation
. | Autologous transplantation . | . | Allogeneic transplantation HLA identical . | . | ||
|---|---|---|---|---|---|---|
. | Children N = 38 . | Adults N = 37 . | Children N = 19 . | Adults N = 32 . | ||
| Median follow-up, mo (range) | 56 (5-162) | 13 (3-126) | 63 (4-166) | 47 (1-139) | ||
| TRM, % | 3 ± 5 | 8 ± 9 | 0 | 26 ± 15 | ||
| Relapse rate, % | 45 ± 16 | 64 ± 18 | 34 ± 24 | 28 ± 17 | ||
| LFS, % | 52 ± 8 | 27 ± 8 | 66 ± 11 | 46 ± 9 | ||
| OS, % | 61 ± 8 | 30 ± 9 | 82 ± 10 | 43 ± 10 | ||
. | Autologous transplantation . | . | Allogeneic transplantation HLA identical . | . | ||
|---|---|---|---|---|---|---|
. | Children N = 38 . | Adults N = 37 . | Children N = 19 . | Adults N = 32 . | ||
| Median follow-up, mo (range) | 56 (5-162) | 13 (3-126) | 63 (4-166) | 47 (1-139) | ||
| TRM, % | 3 ± 5 | 8 ± 9 | 0 | 26 ± 15 | ||
| Relapse rate, % | 45 ± 16 | 64 ± 18 | 34 ± 24 | 28 ± 17 | ||
| LFS, % | 52 ± 8 | 27 ± 8 | 66 ± 11 | 46 ± 9 | ||
| OS, % | 61 ± 8 | 30 ± 9 | 82 ± 10 | 43 ± 10 | ||